Interviews

Ziv J. Haskal, MD, is a pioneer of novel educational methods, and he is excited to bring the benefits of VR educational technology to the CIO audience. Dr. Haskal will present the first virtual reality thyroid ablation case at CIO 2019 on...

Growing an interventional oncology practice presents challenges and takes deliberate, focused work beyond the medical expertise honed in training. Ezana Azene, MD, PhD, recently offered advice on this topic at the recent Society for...

Although most liver tumors are fed by hepatic vessels, a small but significant portion have extrahepatic supply. In this Q&A, William Rilling, MD, FSIR, of the Medical College of Wisconsin in Milwaukee, discusses pre-procedure imaging,...

Many patients require a transfusion to improve platelet counts and reduce risk of bleeding prior to undergoing complex interventional radiology procedures. However, medical treatment with avatrombopag, a thrombopoietin receptor agonist, may...

Uveal melanoma is an orphan disease with an aggressive, rapid course of progression and frequent metastases to the liver. Unlike cutaneous melanoma, there are no effective FDA-approved systemic therapies, but immunoembolization can help to...

Treatment of hepatocellular carcinoma (HCC) continues to rapidly evolve, and interventionalists are confronted with an array of treatment options. Charles Ray, MD, PhD, an interventional radiologist at the University of Illinois College of...

Nicolas Voutsinas, MD, recently presented an abstract at the Society for Interventional Radiology meeting in Austin, Texas. Dr. Voutsinas and his colleagues conducted a single-center, retrospective review of all radiation segmentectomy...

Peptide receptor radionuclide therapy (PRRT) is a potential therapy option for patients with metastatic neuroendocrine tumor, but questions remain about patient selection and treatment decisions in conjunction with arterial therapy,...